2021 Volume 85 Issue 9 Pages 1563-1564
Insufficient salt intake and water restriction are the leading causes of hospital readmission because of an exacerbation of heart failure (HF).1 During the coronavirus disease 2019 epidemic, the number of HF patients with inadequate salt and fluid intake has reportedly increased.2 The Japanese Circulation Society recommends sodium restriction for all patients with HF,3 so it is important to raise awareness and impart knowledge on salt reduction to prevent both the onset and exacerbation of HF.
Article p 1555
In this issue of the Journal, Nakajima et al4 provide a new perspective on the relationship between a behavior change model and the prognosis of HF patients receiving salt reduction guidance. The behavior change model is one of the health theories advocated by Prochaska et al.5,6 Assessment of an HF patient’s behavioral change allows physicians to understand the patient’s psychological state, and, in turn, provide a tailored and person-centered approach to the patient. In their study,4 the salt intake of the patients was not calculated, and only a one-time salt reduction guidance session lasting about 30 min during the hospitalization was performed. Thus, the authors cannot declare that receiving salt reduction instruction directly improved the patient’s prognosis. However, HF patients who made a behavioral change likely had a more favorable prognosis. Eliciting behavioral change by patients involves a multidisciplinary approach and the results of this study support the importance of medical team care for patients with HF.
The Transtheoretical ModelThe behavior change model applied in the study is also called the transtheoretical model (TTM). According to this model, healthy behavior change progresses through 5 stages: indifference (precontemplation), interest period (contemplation), preparation period (preparation), execution period (action), and maintenance period (maintenance) (Figure). A patient trying to achieve good health is in one of these stages. A healthy behavior change requires different information at each stage, and intervention methods are designed according to the stage. Moreover, the model is not one-way, and a person undergoing behavioral transformation can enter the process at any stage, return to a previous stage, or start over.6 Aside from salt reduction guidance in HF patients, TTM has also been used in smoking cessation, alcohol restriction, weight control, and medication guidance.7,8
The transtheoretical model (TTM). In the behavioral transformation stage model, for a person to change a behavior, there are 5 stages to go through: “precontemplation” → “contemplation” → “preparation” → “action” → “maintenance”. “Reversion” occurs when the behavioral change recedes.
HF patients in the precontemplation stage are unwilling to embrace salt-reducing behavior for within 6 months.6 Typical statements include: “I do not feel the need for salt reduction.”; “I am not sure how effective salt reduction is.”; “I am unaware of the benefits of reducing salt and the burden of not doing so.”; “I am not thinking of doing anything to reduce my salt.”; and “I think that the burden of salt reduction is heavy.” Therefore, it is crucial for patients at this stage to work on psychological and behavioral aspects: (A) considering the benefits of salt reduction in the treatment of HF; (B) obtaining knowledge and information on effective salt reduction and finding awareness of salt reduction and salt reduction behavior (raising awareness and emotional experience); (C) knowing that excess salt is the cause of exacerbation of HF and readmission; (D) being aware of the real reason why they cannot reduce salt and make excuses.
HF patients in the contemplation stage are not currently undertaking salt-reducing behavior, but they are willing to do so for 6 months.6 They feel hesitant or procrastinate in terms of the behavioral change. The following statements describe the feelings and perceptions of these patients: “I am interested in the benefits of reduced salt, but I am not ready to do it right away.”; “I am not sure what to start with, and I am worried if I can do it.”; and “I think it is better to stay as it is than to reduce salt.” Therefore, it is crucial for patients at this stage to achieve the following: (A) deciding on specific actions to be taken; (B) reducing the burden of salt reduction and enhancing the benefits of salt reduction; (C) increasing awareness of salt reduction (raise awareness, emotional experience); (D) changing their self-image (reassessment of self and self-efficacy).
Behavioral Change and Prognosis in HF PatientsIn this study, the prognosis of HF patients in the non-active states (precontemplation, contemplation, and preparation stages) was good.4 The differences in the backgrounds of HF patients need consideration. The health interventions in the health guidance improved the prognosis by increasing the TTM stage after the patients were discharged. Patients with a lower TTM level (non-active state) had better health consciousness after undergoing salt reduction and lifestyle guidance. In actual clinical practice, the effect of salt reduction guidance on sodium restriction is limited. The achievement rate of salt reduction guidance in patients with HF is approximately 25%.9,10 However, even if HF patients do not reach their daily salt limit target, their prognosis can still improve with self-management and family support for salt reduction.11 Further studies on HF treatment and lifestyle modifications through salt reduction guidance, rather than imparting knowledge on salt reduction target values, are needed.
How the leader (healthcare worker) decides on the “goal setting” in collaboration with the target patient, and how much support is provided to achieve the goals, are the “keys” to success in behavioral change. When managing HF patients, it is important to render consistent medical team care in cooperation with multiple disciplines, such as doctors, nurses, pharmacists, nutritionists, and physiotherapists, according to the pathological condition and treatment of stage.3 Continuous care and guidance by the healthcare professionals improve the HF patient’s motivation for treatment, leading to an improvement in prognosis.11
The authors declare no conflicts of interest.